Ignite Creation Date:
2025-12-24 @ 11:18 PM
Ignite Modification Date:
2026-02-19 @ 8:47 PM
Study NCT ID:
NCT01896856
Status:
COMPLETED
Last Update Posted:
2020-10-06
First Post:
2013-07-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase I/II Study of SGI-110 With Irinotecan Versus Regorafenib or TAS-102 in Metastatic Colorectal Cancer
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10-23
Start Date Type:
ACTUAL
Primary Completion Date:
2019-08-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-08-26
Completion Date Type:
ACTUAL
First Submit Date:
2013-07-08
First Submit QC Date:
None
Study First Post Date:
2013-07-11
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-08-24
Results First Submit QC Date:
None
Results First Post Date:
2020-09-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-09-14
Last Update Post Date:
2020-10-06
Last Update Post Date Type:
ACTUAL